Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research  How it helps Latest publication
Avoralstat
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021
Adjuvanted SARS-CoV-2 Spike protein
Potential treatment - pre-clinical evidence Experimental Vaccine Apr/01/2021
candidate vaccine (Sanofi + GSK)
Potential treatment - clinical evidence Experimental Vaccine Mar/26/2020
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
Azanitrile 8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
Pyridyl ester 17
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
ΔABP-α2
Potential treatment - theoretical effect Experimental Antiviral Mar/01/2021
GRL0617
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/20/2021
J08-MUT
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/23/2021
VS12
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
Bis4
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
Bis3
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
C2 (IgG)
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/15/2021
2-Bromo-3-fluoro-N-[(1-methyl-1H-indol-3-yl)sulfonyl]benzamide
Potential treatment - theoretical effect Experimental Antiviral Feb/20/2021
Hydroxyitraconazole
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
VS10
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021
7-chloro-2-((3,5-dichlorophenyl)amino)quinazolin-4(3H)-one
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021
2-((3,5-dichlorophenyl)amino)-5-hydroxyquinazolin-4 (3H)-one
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021
mAb 2-36
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
S-Trimer
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/01/2021